Lakers to be sold in record-breaking $10 billion deal: ESPN
The Los Angeles Lakers are being sold in a record-breaking $10 billion deal that makes the iconic franchise the highest-valued sports team in US history, ESPN reported Wednesday.
The report said the Lakers owners, the Buss family, would sell their controlling interest in the team to billionaire Mark Walter, who already owns a stake in the franchise.
While Jeanie Buss would continue as Lakers governor, the deal ends the Buss family's 47-year reign over the NBA giants.
Walter is the chief executive of holding company TWG Global which has built an impressive portfolio of professional sports teams, including the Los Angeles Dodgers and Los Angeles Sparks.
TWG also owns the Billie Jean King Cup tennis tournament and the Cadillac Formula One team.
While further specifics of the deal were not disclosed, Lakers legend Magic Johnson -- a business partner of Walter -- was among the first to react to news of the agreement.
"Laker fans should be ecstatic," Johnson wrote on X. "A few things I can tell you about Mark - he is driven by winning, excellence, and doing everything the right way. And he will put in the resources needed to win! I can understand why Jeanie sold the team to Mark Walter because they are just alike."
Johnson cited Walter's ownership of the Los Angeles Dodgers baseball team as a reason for optimism. The Dodgers have won the World Series twice since Walter's ownership group took the club over.
"Mark is the best choice and will be the best caretaker of the Laker brand," Johnson wrote. "The proof is in the pudding on what he's been able to accomplish with the LA Dodgers. Mark has been nothing short of a winner."
The end of the Buss family's control of the Lakers marks the end of an era in the NBA.
The team were bought by charismatic tycoon Jerry Buss in 1979, who quickly helped turn the franchise into a sporting powerhouse as well as a globally recognised brand.
The Buss era brought the Lakers 11 NBA championships -- more than any other team over the same period -- and encompassed golden ages which included the "Showtime" Lakers of Magic Johnson as well as a hat-trick of championships between 2000-2002 when the team was spearheaded by Kobe Bryant.
Walter has been a minority owner of the Lakers since 2021 when he bought a share of the team in a deal which also gave him first refusal to buy the club should the Buss family ever decide to sell.
The sale of the club smashes the previous highest figure paid for a US sports team, the $6.1 billion paid for the Boston Celtics earlier this year.
That Celtics sale eclipsed the $6.05 billion that Josh Harris paid for the Washington Commanders in 2023.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
an hour ago
- News.com.au
Health Check: On Garfield the Cat Day, the biotech sector purrs with deals and breakthroughs
Orthocell says its Remplir nerve device blitzes the stitches Singular Health inks US physician network deal Clarity clearly is undervalued, say brokers Among other auspicious events, the 19th of June marks the end of slavery in the US, Garfield the Cat Day and the birthdays of former British PM Boris Johnson and royal temptress Wallis Simpson. So why not add a slew of meaningful life sciences announcements, including an HIV vaccine breakthrough, to the June 19 pantheon? Let's start with Orthocell (ASX:OCC), which reports 'compelling data' showing its Remplir nerve repair agent is superior to suture-only standard techniques. Stitching accounts for circa 90% of the 700,000 nerve repair procedures done in the US annually. A cuff that envelops the damaged peripheral nerves, Remplir reduces the use of stitching, which can compromise nerve repair. Orthocell's study used a rat sciatic nerve injury model, covering 48 rodents across four treatment groups. These cohorts covered repairs using one, three or six sutures, compared with one suture augmented with Remplir. The rats' nerve function and regeneration were evaluated up to 12 weeks post-treatment. The FDA ticked off Remplir in early April and the device is also approved in Canada, Hong Kong, Singapore, New Zealand and here. Thus, the study was pitched not so much as approval as supporting the US sales rollout. Orthocell cites a total addressable market in its target markets of US$3.5 billion, with its already-approved geographies accounting for US$1.8 billion. The US market is worth US$1.6 billion. Stem-cell hope for bone marrow transplant patients NeuroScientific Biopharmaceuticals (ASX:NSB) highlights previous clinical data showing its soon-to-be acquired stem cell platform is effective in preventing graft-versus-host disease (GvHD). The company is buying the asset, Stemsmart from the unlisted Perth-based Isopogen. The phase I work covered adults and children with life-threatening, steroid-resistant GvHD, a common complication of bone-marrow transplants. The data shows the treatment is safe and well tolerated, 'with no infusion related toxicities'. Furthermore, most adults and children had a 'complete or partial resolution of symptoms and improved survival'. Of the 10 children treated on compassionate grounds, all had survived 12 months post implant. Three of them were still alive six years post treatment. Turning to pancreatic cancer, Amplia (ASX:ATX) reports another patient with a 'complete response' in its 55-patient trial dubbed Accent. As close as dammit to a cure, a confirmed complete response formally is defined as all tumour lesions disappearing, with the effect maintained for at least two months. 'This is a rare outcome in advanced pancreatic cancer where the disease has spread to other parts of the body,' the company says. A Singularly fine US deal Imaging medtech outfit Singular Health Group Ltd (ASX:SHG) has signed a $2 million agreement with a US physician network to develop and use Singular's 3Dicom medical imaging tool. The compact is with Provider Network Solutions (PNS), covering physician networks in Puerto Rico, Florida, and Texas. It covers the initial deployment of 1000 3Dicom licences, at US$800 each. Singular pockets a further US$500,000 on 'satisfaction of AI model marketplace and image repository development and integration'. The company hope to expand to the remaining 30 states that PNS covers. 3Dicom converts magnetic resonance imaging and computed tomography scans to enable 'immersive visualisation' with three-dimensional images. Singular also said it had received $8 million of firm commitments in its recently-announced placement. Meanwhile, microbiome testing house Microba Life Sciences (ASX:MAP) is on trading halt pending a capital raising. EZZ girds for US launch Hitherto China and locally focused, health supplements outfit EZZ Life Science (ASX:EZZ) has launched four initial products into the US after winning FDA approval. To be sold under the new Ezzday banner, the products are made in the US and are tailor-made for American consumers. Seeing you asked, the remedies cover de-bloating/de-gassing, vaginal probiotics, skincare and colon detox. Readers can draw their own conclusions as to what that means about the State of the Nation in Trumpian times. Initially, the products will be sold via Amazon and Shopify. Locally EZZ sells via more than 600 chemists and globally via 750 ecommerce platforms, including China's Douyin and Tmall. The company values the US supplements market at US$100 billion a year, pipping China's US$80 billion opportunity. US health secretary Robert F Kennedy Junior (RFK Jr) has a special interest in health supplements, which at the very least shouldn't harm EZZ's US ambitions. EZZ shares have been on a tear – up 33% over the last month – but they are still well shy of the record $5 peak in October last year. HIV jab spells hope for end to '45-year pandemic' Speaking of RFK Jr, the FDA has approved a drug that is meant to protect against HIV with a single administration every six months. Yep – it's a vaccine – so maybe the health czar isn't as avowedly anti-vaxx as we all think. Marketed as Yeztugo by Gilead Sciences, lenacapavir is seen as the best hope of knocking HIV – in effect a 45-year pandemic – on its head. Clinicians say the drug is much more powerful than the current oral treatments and almost 100% effective. 'This is a historic day in the decades-long fight against HIV,' Gilead CEO Daniel O'Day said. 'Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic.' The drug has a list price of US$28,218 ($43,300). But Gilead may provide the vaccine free to non-insured patients. Have investors underestimated Clarity? Is radiopharmacy outfit Clarity Pharmaceuticals (ASX:CU6) a case of 'objects in this rear view mirror are closer than you think'? Following a series of clinical updates from Clarity, broker Canaccord values the company at $6.74 a share, a lofty 210% increment on the current price. In March, Wilsons ascribed an even ballsier $8.25 a share. All things being equal – and they never are – that would value Clarity at $2.6 billion. Sector champ Telix Pharmaceuticals (ASX:TLX) is worth around $8 billion, bearing in mind it has two FDA-approved prostate cancer imaging tools and a kidney cancer consent in the offing. Yesterday, Clarity said it has struck an agreement with US mob Spectronrx. Spectronrx will provide 400,000 patient-ready does of its copper isotope based 64Cu-SAR-bisPSMA (for diagnosing and potentially treating prostate cancer). In the nuclear medicine game, gaining access to nearby doses is half the battle. But this agent's generous half-life means it can be distributed across all 50 US states. Clarity recently announced promising phase II results for 64Cu-Sartate (neuroblastoma) and 64Cu-SAR-Bombesin (PSMA-negative prostate cancer). Another program, Secure, focuses on identifying and treating metastatic castration-resistant prostate cancer. Clarity currently has no approved products, but Canaccord expects 64Cu-SAR-bisPSMA to be on market by mid 2027. 'Recent commercial agreements should remind the market that this potential best-in-class asset could be closer than we think.' The firm reckons Clarity can win a 20% share of the US market, for US$520m in peak sales. Your columnist's nuclear science credentials – the ones plucked from a Weeties pack – are out of date. But it looks like Telix should have one eye on the rear-view mirror and the other on the road ahead.
News.com.au
2 hours ago
- News.com.au
Auction of Pope Leo XIV's childhood Chicago home extended
The highly-publicised auction of Pope Leo XIV's childhood home has been extended by a month — after it was revealed the Chicago suburb where he was raised was launching a bid to acquire the humble dwelling so it can be preserved as a local landmark. Pope Leo, who was born Robert Francis Prevost, spent several years living in a small three-bedroom, three-bathroom dwelling in Dolton, Illinois. His father, Louis Prevost, sold the property in 1996, according to records, after which it was sold on two other occasions. According to Realtor, the current owner, property flipper Pawel Radzik, acquired the three-bedroom, three-bathroom abode in March 2024 for $US66,000 ($A101,553) and had initially planned to renovate it, then sell it off — until that is, one of its former residents was chosen to succeed the late Pope Francis during the conclave in May. At the time, the property was on the market for just $US199,900 ($A307,605); however, it was swiftly delisted just hours after Pope Leo's new historical role was revealed. It was later revealed the home was being put up for auction via Paramount Realty USA — with listing agent Steve Budzik noting the decision to sell the property to the highest bidder came after his team struggled to settle on an appropriate listing price for an abode with such historical significance. However, the home's journey took another twist when the Village of Dolton, with support from the Chicago Archdiocese, announced plans to acquire the house, either by buying it, or by using eminent domain to take over ownership. 'The Village of Dolton intends to purchase this home either through direct purchase or through their eminent domain power,' Odelson wrote in a letter sent to Paramount Realty USA, according to the New York Times. 'The Village intends to work with the Chicago Archdiocese and other agencies to allow the home to be viewed and visited by the public as a historic site.' Odelson added discussions with the seller were underway, saying the Village of Dolton and the local archdiocese would prefer not to rely on eminent domain for the acquisition of the home because it would garner too much media attention. '[It] keeps the home in the news and not the light that the village or the church want,' he said. 'We don't want it to be a controversy; we want it to be a sacred site.' Initially, the auction of the property was due to close on June 18. However, an update to the listing has now extended the bidding process to July 17, with Budzik explaining to via email this was done in order to 'allow more time for bidders to review, perform due diligence, and bid'. A spokesperson for Paramount Realty USA added the extended auction window will also give bidders an opportunity to 'tour the property' if they wish. Neither Budzik nor Paramount Realty USA commented on whether negotiations with the Village of Dolton had any bearing on the decision to extend the auction. After Dolton announced its plans to acquire the home, Budzik told his client was very much open to working with its representatives, as well as the Chicago Archdiocese, stating in an email: 'The seller is open to the potential opportunity of working with the Village of Dolton to purchase the property at fair market value. 'We also understand that the Chicago Archdiocese could be involved in making this a historical landmark, which is great news for the seller. We would love to come to a mutually beneficial agreement in the coming days.' To make matters more complicated, CBS News reported on June 16 a motion had been filed seeking a preliminary injunction to block the Village of Dolton from using taxpayer money in order to buy Pope Leo's childhood home. This motion is understood to have been filed as part of an ongoing wrongful termination lawsuit filed against Dolton by a former employee, Lavell Redmond, who claimed in a 2022 filing that his employers had refused to discuss terms of a settlement because the village did not have sufficient funds. In his June 15 motion, Redmond's lawyers claimed Dolton is in 'severe financial distress' and made several allegations of financial mismanagement, unresolved legal obligations, and a potential misuse of taxpayer funds. Matthew R. Custardo, the lawyer who filed the motion, stated to WGN9 the injunction was being sought in order to stop 'hypocrisy,' insisting the injunction would in no way hinder the sale of the home but rather prevent local politicians from using taxpayer funds in order to take it over. 'This isn't about stopping history. It's about stopping hypocrisy,' he said. 'You can't cry broke in court and then try to spend taxpayer funds on non-essential acquisitions.' While bids for the property start at $US250,000 ($A385,148), it is widely predicted the home could sell for much more, although experts have hesitated to put a specific value on the property in the weeks since the auction was announced. The online auction house also provides a copy of the original purchase deed from the 1949 sale of the home to Pope Leo's father, Louis, which is dated March 3 of that year.
News.com.au
3 hours ago
- News.com.au
Donald Trump Jr set to open private club with $768k fee
President Donald Trump's eldest son, Don Trump Jr, is launching a new private members club that will cater to the wealthiest supporters of his father's administration. Named 'Executive Branch,' the invite-only venue in Washington, DC's Georgetown neighbourhood will charge members a $US500,000 ($A768,000) joining fee as well as annual dues, which have not yet been revealed publicly, Realtor reports. Speaking to The Washington Post, Don Jr's business partner in the venture, Omeed Malik, revealed the aim of the club is to provide a space that is 'friendly to Republicans,' something the founders believe will fill a large gap in the market. 'During the 2024 campaign, many of us developed deep friendships and wanted to be able to catch up when our paths crossed in DC,' he explained. 'There aren't a plethora of options that are friendly to Republicans — examples of that abound — and we needed a space where friends can converse without worrying about their conversations showing up in the press the next day.' The outlet notes the club will offer a 'health-conscious menu' with 'nods' to RFK Jr's Make American Healthy Again initiative. In other words, beef tallow will abound, but seed oils will likely be checked at the door. There will be an array of American dishes on the menu — as well as Mediterranean and Japanese-inspired options — with plenty of cocktails and high-end wines included in the offerings. Memberships will be tiered, per CNBC, and only 200 were made available in the first round, which had already led to a lengthy waiting list as of the end of April, the outlet reported. Among the founding members are a number of well-known characters, including crypto entrepreneurs Tyler and Cameron Winklevoss, tech investor David Sacks, and venture capitalist Chamath Palihapitiya. Only a select group of individuals were given the opportunity to become founding members or provided with a chance to join the highest (and most expensive) tier of memberships; however, other, lower-cost options are available, with fees ranging in the 'low six figures,' The Washington Post reported. According to Mr Malik, the aim is to create a truly luxurious experience for members — one that rivals some of the finest private establishments in the world — such as No. 5 Hertford St in London or Carriage House in Palm Beach. '[We wanted] a high-end experience comparable to the finest social clubs in the world,' he said, before questioning: 'Why shouldn't our nation's capital have a luxury venue like other major metropolitan cities?'
